{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:24Z","timestamp":1786987524509,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.cpcardiol.2021.100994","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T15:03:51Z","timestamp":1632495831000},"page":"100994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study"],"prefix":"10.1016","volume":"47","author":[{"given":"Ashot","family":"Avagimyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lusine","family":"Mkrtchyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orest","family":"Abrahomovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Sheibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astkhik","family":"Guevorkyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6828-2169","authenticated-orcid":false,"given":"Nizal","family":"Sarrafzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Kozhukhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Agati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Astengiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zaritska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinaida","family":"Jndoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2021.100994_bib0001","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/ehf2.12386","article-title":"Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018","volume":"5","author":"Anker","year":"2018","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0002","doi-asserted-by":"crossref","first-page":"56","DOI":"10.25040\/lkv2019.04.051","article-title":"Cardiotoxicity of chemotherapy: case report and literature review","volume":"4","author":"Avagimyan","year":"2019","journal-title":"Lviv Clinical Bulletin"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0003","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","article-title":"Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry","volume":"41","author":"L\u00f3pez-Send\u00f3n","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0005","article-title":"Anthracycline associated disturbances of cardiovascular homeostatsis","author":"Avagimyan","year":"2021","journal-title":"Current Problems of Cardiology"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0006","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2020.00026","article-title":"Cardiotoxicity of Anthracyclines","volume":"7","author":"Cardinale","year":"2020","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0007","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1152\/physrev.00022.2011","article-title":"Sirtuin 1 and sirtuin 3: physiological modulators of metabolism","volume":"92","author":"Nogueiras","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0008","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fonc.2020.00474","article-title":"Sirt4: A multifaceted enzyme at the crossroads of mitochondrial metabolism and cancer","volume":"10","author":"Tomaselli","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0009","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1515\/hsz-2016-0316","article-title":"The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction","volume":"398","author":"Dolinsky","year":"2017","journal-title":"Biol Chem"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0010","doi-asserted-by":"crossref","first-page":"10981","DOI":"10.1074\/jbc.M114.607960","article-title":"Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes","volume":"290","author":"Cheung","year":"2015","journal-title":"J of Biol Chem"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0011","first-page":"579","article-title":"Cardio-oncology: vascular and metabolic perspectives: a scientific statement from the","volume":"139","author":"Umberto","year":"2019","journal-title":"American Heart Assoc Circul"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0012","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacbts.2018.06.005","article-title":"Role of Endothelium in Doxorubicin-Induced Cardiomyopathy","volume":"3","author":"Luu","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0013","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)","volume":"41","author":"Knuuti","year":"2020","journal-title":"European Heart J"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.569132","article-title":"Trimetazidine in Heart Failure","volume":"11","author":"Shu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0015","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0003319720987745","article-title":"Efficacy of trimetazidine in limiting periprocedural myocardial injury in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"72","author":"Wang","year":"2021","journal-title":"Angiology"},{"key":"10.1016\/j.cpcardiol.2021.100994_bib0016","doi-asserted-by":"crossref","unstructured":"Svanidze T, Saralidze T, Mamatsashvili I, Bediashvili T. P1587 Echocardiographic estimation of the impact of long-term treatment with Trimetazidine on myocardial dysfunction in patients with ST elevation myocardial infarction. European Heart J Cardiovas Imaging 21(Supplement_1). https:\/\/doi.org\/10.1093\/ehjci\/jez319.1007.","DOI":"10.1093\/ehjci\/jez319.1007"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621002097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280621002097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:00:57Z","timestamp":1758938457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280621002097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0146280621002097"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100994","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.100994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100994"}}